Clinical trial
092206: Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) From PANCRECARB® (Pancrelipase), Delayed Release Capsules, Buffered and Enteric-Coated Microspheres
NCT00749099 is registered in ClinicalTrials.gov with Digestive Care, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 092206: Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) From PANCRECARB® (Pancrelipase), Delayed Release Capsules, Buffered and Enteric-Coated Microspheres
- Lead sponsor
- Digestive Care, Inc.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2007
- Completion date
- September 30, 2010
- Enrollment
- 11 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.